PANACIL is a gastrointestinal composition (GIC) of natural ingredients. It has been approved by Health Canada as an OTC product for the relief of constipation and for the promotion of bowel movements. It is registered and patented in Canada, and either patented or patentable in many other countries.

On the basis of a limited study, this GIC was found to be effective for the relief of acidity and heartburn, for inhibiting the occurrence and recurrence of gastro-duodenal ulcers, and for the prevention of gastrointestinal upset, bleeding and hemorrhoids. It also appears to be effective in reducing the side effects of anti-ulcer drugs and for alleviating discomfort caused by gastro-esophageal reflux, etc.

This non-systemic product may not compete with synthetic anti-ulcer drugs, such as Tagamet, Zantec, Pepcid, Losac etc. at the receptor sites in the gastro-duodenal area.

Indeed, PANACIL has the potential to help millions of people suffering needlessly from gastrointestinal ailments.